Fawell Stephen
SEC insider (Form 3/4/5 filer). CIK 0002033387. Director at C4 Therapeutics, Inc. (CCCC). 3 reported Form 4/5 transactions since Sep 2024; latest on Jun 24, 2026. Located in WATERTOWN, MA.
Companies Fawell Stephen has filed insider reports for
- C4 Therapeutics, Inc. (CCCC): Director
Fawell Stephen
CIK: 0002033387
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)3 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
CCCC
C4 Therapeutics, Inc.
Director
Discretionary Trading P&L
Holdings
Transaction History (3 total)
- Jun 24, 2026CCCC
C4 Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
62K shares- - Jun 18, 2025CCCC
C4 Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
35.5K shares- - Aug 29, 2024CCCC
C4 Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
65K shares-
1-3 of 3 transactions